Price $4.55 |
Market Cap
53.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
9.1
|
P/B
1.36
|
P/S
0.96
|
Dividend %
-
|
|
P/CF
6.6
|
P/FCF
7.5
|
Op. Cash Flow
10.7K
|
FCF
0.6
|
|
Op. Margin
10.00%
|
Net Margin
11.10%
|
ROE
17.50%
|
ROI
12.30%
|
|
ROA
11.60%
|
EPS Growth
292.10%
|
Current Ratio
2.3
|
Debt/Equity
5.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Valeant Pharmaceuticals Intl I (VRX) | $14.42 | - | - | 5.95B | Strong Buy |
| RTI Surgical Inc (RTIX) | $4.65 | - | - | 322.1M | Strong Buy |
| CV Sciences Inc (CVSI) | $0.24 | - | - | 22.8M | Strong Buy |
| Bioanalytical Systems, Inc. (BASI) | $1.62 | - | - | 15.5M | Strong Buy |
| iCAD Inc (ICAD) | $3.36 | - | - | 64.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
